Pirfenidone
4 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Pirfenidone as a Radiosensitizer in the Treatment of Head and Neck Squamous Cell Carcinoma (NCT06142318) | Nanfang Hospital, Southern Medical University | 2023-11-15 |
| Efficacy and Safety of Pirfenidone in CTD-ILD (NCT05505409) | Qilu Hospital of Shandong University | 2022-06-22 |
| A Study to Evaluate the Efficacy and Safety of Pirfenidone With Novel Coronavirus Infection (NCT04282902) | Huilan Zhang | 2020-02-04 |
| Immunosuppressant Combined With Pirfenidone in CTD-ILD (NCT04928586) | Qilu Hospital of Shandong University | 2019-08-16 |
Track Pirfenidone automatically
Every clearance here is in the API, with alerts when new ones post.